Ignite Creation Date:
2024-05-05 @ 4:44 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00309907
Status:
COMPLETED
Last Update Posted:
2017-09-29
First Post:
2006-03-29
Brief Title:
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Sponsor:
Childrens Oncology Group
Organization:
Childrens Oncology Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Secondary Myelodysplastic Syndromes |
| Accelerated Phase Chronic Myelogenous Leukemia |
| Blastic Phase Chronic Myelogenous Leukemia |
| Childhood Acute Lymphoblastic Leukemia in Remission |
| Childhood Acute Myeloid Leukemia in Remission |
| Childhood Chronic Myelogenous Leukemia |
| Childhood Myelodysplastic Syndromes |
| Chronic Phase Chronic Myelogenous Leukemia |
| de Novo Myelodysplastic Syndromes |
| Disseminated Neuroblastoma |
| Juvenile Myelomonocytic Leukemia |
| Previously Treated Childhood Rhabdomyosarcoma |
| Previously Treated Myelodysplastic Syndromes |
| Pulmonary Complications |
| Recurrent Childhood Acute Lymphoblastic Leukemia |
| Recurrent Childhood Acute Myeloid Leukemia |
| Recurrent Childhood Large Cell Lymphoma |
| Recurrent Childhood Lymphoblastic Lymphoma |
| Recurrent Childhood Rhabdomyosarcoma |
| Recurrent Childhood Small Noncleaved Cell Lymphoma |
| Recurrent Neuroblastoma |
| Recurrent Wilms Tumor and Other Childhood Kidney Tumors |
| RecurrentRefractory Childhood Hodgkin Lymphoma |
| Relapsing Chronic Myelogenous Leukemia |
| Secondary Acute Myeloid Leukemia |
Keywords: